UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease

Neurology, 2017-05, Vol.88 (19), p.1814-1821

2017

Volltextzugriff (PDF)

Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer's disease

Journal of integrative neuroscience, 2021-12, Vol.20 (4), p.861-870

2021

Volltextzugriff (PDF)

The structural MRI markers and cognitive decline in prodromal Alzheimer's disease: a 2-year longitudinal study

Quantitative imaging in medicine and surgery, 2018-11, Vol.8 (10), p.1004-1019

2018

Volltextzugriff (PDF)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer's Disease

Frontiers in aging neuroscience, 2021-04, Vol.13, p.667899-667899

2021

Volltextzugriff (PDF)

CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorder

Translational neurodegeneration, 2018-10, Vol.7 (1), p.22-22, Article 22

2018

Volltextzugriff (PDF)

Protective effects of diazoxide against Aβ25–35-induced PC12 cell apoptosis due to prevention of endoplasmic reticulum stress

Neuroreport, 2012-05, Vol.23 (8), p.493-497

2012

Volltextzugriff (PDF)

Headache Secondary to Isolated Sphenoid Sinus Fungus Ball: Retrospective Analysis of 6 Cases First Diagnosed in the Neurology Department

Frontiers in neurology, 2018-09, Vol.9, p.745-745

2018

Volltextzugriff (PDF)

Reader response: Type 2 diabetes mellitus, brain atrophy, and cognitive decline

Neurology, 2020-01, Vol.94 (1), p.48-49

2020

Volltextzugriff (PDF)

Characterizing biomarker features of cognitively normal individuals with ventriculomegaly

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2018, Vol.10 (1), p.12-21

2018

Volltextzugriff (PDF)

Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats

Neurochemical research, 2006-11, Vol.31 (11), p.1337-1347

2006

Volltextzugriff (PDF)

Detection of Tau-PET Positivity in Clinically Diagnosed Mild Cognitive Impairment with Multidimensional Features

Journal of Alzheimer's disease, 2023-01, Vol.94 (2), p.627-640

2023

Volltextzugriff (PDF)

Predicting amyloid‐PET and clinical conversion in apolipoprotein E ε3/ε3 non‐demented individuals with multidimensional factors

The European journal of neuroscience, 2024-07, Vol.60 (1), p.3742-3758

2024

Volltextzugriff (PDF)

Hippocampal volume maximally modulates the relationship between subsyndromal symptomatic depression and cognitive impairment in non-demented older adults

Journal of affective disorders, 2024-09, Vol.367, p.640-646

2024

Volltextzugriff (PDF)

Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats

Brain research, 2009-06, Vol.1276, p.171-179

2009

Volltextzugriff (PDF)

Successful management of cerebral venous sinus thrombosis due to adenomyosis: Case reports and literature review

Clinical neurology and neurosurgery, 2023-06, Vol.229, p.107726-107726, Article 107726

2023

Volltextzugriff (PDF)

Landmark-based spherical quasi-conformal mapping for hippocampal surface registration

Quantitative imaging in medicine and surgery, 2024-06, Vol.14 (6), p.3997-4014

2024

Volltextzugriff (PDF)

Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications

Brain research, 2007-01, Vol.1127 (1), p.177-184

2007

Volltextzugriff (PDF)

Repetitive transcranial magnetic stimulation for treatment of lactacystin-induced Parkinsonian rat model

Oncotarget, 2017-08, Vol.8 (31), p.50921-50929

2017

Volltextzugriff (PDF)

Regulation of adenosine triphosphate-sensitive potassium channels suppresses the toxic effects of amyloid-beta peptide (25-35)

Neural regeneration research, 2013-01, Vol.8 (1), p.56-63

2013

Volltextzugriff (PDF)

Tat-Src reduced NR2B tyrosine phosphorylation and its interaction with NR2B in levodopa-induced dyskinetic rats model

Behavioural brain research, 2019-01, Vol.356, p.41-45

2019

Volltextzugriff (PDF)

An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease

Oncotarget, 2017-08, Vol.8 (34), p.57316-57326

2017

Volltextzugriff (PDF)

Regulation of adenosine triphosphate-sensitive potassium channels suppresses the toxic effects of amyloid-beta peptide (25-35)

Neural regeneration research, 2013-01, Vol.8 (1), p.56

2013

Volltextzugriff (PDF)

Repetitive transcranial magnetic stimulation (rTMS) improves behavioral and biochemical deficits in levodopa-induced dyskinetic rats model

Oncotarget, 2016-09, Vol.7 (37), p.58802-58812

2016

Volltextzugriff (PDF)

NR2B antagonist CP-101,606 inhibits NR2B phosphorylation at tyrosine-1472 and its interactions with Fyn in levodopa-induced dyskinesia rat model

Behavioural brain research, 2015-04, Vol.282, p.46-53

2015

Volltextzugriff (PDF)

Postsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat models

Drug design, development and therapy, 2015-01, Vol.9, p.199-206

2015

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(44)
Buchkapitel
(1)

Sprache

Englisch
(45)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease

Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer's disease

The structural MRI markers and cognitive decline in prodromal Alzheimer's disease: a 2-year longitudinal study

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer's Disease

CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorder

Protective effects of diazoxide against Aβ25–35-induced PC12 cell apoptosis due to prevention of endoplasmic reticulum stress

Headache Secondary to Isolated Sphenoid Sinus Fungus Ball: Retrospective Analysis of 6 Cases First Diagnosed in the Neurology Department

Reader response: Type 2 diabetes mellitus, brain atrophy, and cognitive decline

Characterizing biomarker features of cognitively normal individuals with ventriculomegaly

Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats

Detection of Tau-PET Positivity in Clinically Diagnosed Mild Cognitive Impairment with Multidimensional Features

Predicting amyloid‐PET and clinical conversion in apolipoprotein E ε3/ε3 non‐demented individuals with multidimensional factors

Hippocampal volume maximally modulates the relationship between subsyndromal symptomatic depression and cognitive impairment in non-demented older adults

Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats

Successful management of cerebral venous sinus thrombosis due to adenomyosis: Case reports and literature review

Landmark-based spherical quasi-conformal mapping for hippocampal surface registration

Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications

Repetitive transcranial magnetic stimulation for treatment of lactacystin-induced Parkinsonian rat model

Regulation of adenosine triphosphate-sensitive potassium channels suppresses the toxic effects of amyloid-beta peptide (25-35)

Tat-Src reduced NR2B tyrosine phosphorylation and its interaction with NR2B in levodopa-induced dyskinetic rats model

An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease

Regulation of adenosine triphosphate-sensitive potassium channels suppresses the toxic effects of amyloid-beta peptide (25-35)

Repetitive transcranial magnetic stimulation (rTMS) improves behavioral and biochemical deficits in levodopa-induced dyskinetic rats model

NR2B antagonist CP-101,606 inhibits NR2B phosphorylation at tyrosine-1472 and its interactions with Fyn in levodopa-induced dyskinesia rat model

Postsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat models

Suchergebnisse filtern